Skip to content
Login
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Login
Login
Account Settings
Login
Login
Account Settings
Login
Sign Up
Real Clinics. Real Patients. Real Oncology.
Home
/
Topics
/
Cancer Types
/
Hematologic Malignancies
Home /
Hematologic Malignancies
Hematologic Malignancies
Hematologic Malignancies
Recent Updates
Epigenetic Therapy Shows Promise Against Treatment-Resistant AML
July 27, 2026
Recent Updates
Practices Partner to Increase Access to Cancer Care in Northeastern Indiana Communities
July 20, 2026
FDA Approvals
Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients
April 16, 2026
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Grant Drew
, PharmD;
Kiwon Park
, PharmD, et al.
April 16, 2026
Recent Updates
Epigenetic Therapy Shows Promise Against Treatment-Resistant AML
July 27, 2026
Recent Updates
Practices Partner to Increase Access to Cancer Care in Northeastern Indiana Communities
July 20, 2026
FDA Approvals
Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients
April 16, 2026
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Grant Drew
, PharmD;
Kiwon Park
, PharmD, et al.
April 16, 2026
News & Insights
Recent Updates
Epigenetic Therapy Shows Promise Against Treatment-Resistant AML
July 27, 2026
Recent Updates
Practices Partner to Increase Access to Cancer Care in Northeastern Indiana Communities
July 20, 2026
FDA Approvals
Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients
April 16, 2026
FDA Approvals
Reconsidering Venetoclax Dosing With Azole Antifungals
Grant Drew
, PharmD;
Kiwon Park
, PharmD, et al.
April 16, 2026
Podcasts
No results were found
Leukemia
Lymphoma
Multiple Myeloma
What are you looking for?
Search
Search
POPULAR SEARCHES
Adjuvant Therapy
Bladder Cancer
Blood-Based Tests
Breast Cancer
